Company Filing History:
Years Active: 2018
Title: Claus-Peter Czerny: Innovator in Nucleic Acid Detection
Introduction
Claus-Peter Czerny is a notable inventor based in Waake-Boesinghausen, Germany. He has made significant contributions to the field of nucleic acid detection, particularly in the detection of Mycobacterium avium subsp. paratuberculosis (MAP). His innovative work has led to the development of a patented method that enhances the specificity and quantification of MAP in biological samples.
Latest Patents
Czerny holds one patent that focuses on a method for specifically detecting and optionally quantifying MAP in a sample. This patent involves the detection of the IS900 region in a sample through nucleic acid amplification using specific oligonucleotides. Additionally, it describes a test kit designed for the specific detection of MAP by amplification methods, along with specific oligonucleotides suitable for this purpose.
Career Highlights
Czerny is affiliated with the Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, where he contributes to research and innovation in his field. His work is characterized by a commitment to advancing methodologies that improve the accuracy of pathogen detection.
Collaborations
Czerny collaborates with Pia Muenster, enhancing the research output and innovation potential in their projects. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
Claus-Peter Czerny is a distinguished inventor whose work in nucleic acid detection has significant implications for medical diagnostics. His contributions continue to influence the field and pave the way for future innovations.